Shanrong Biotechnology Total Asset vs. Price To Sales
| SRBT Stock | USD 0.1 0.00 0.00% |
For Shanrong Biotechnology profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Shanrong Biotechnology to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Shanrong Biotechnology Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Shanrong Biotechnology's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Shanrong Biotechnology Corp over time as well as its relative position and ranking within its peers.
Shanrong |
Shanrong Biotechnology Price To Sales vs. Total Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Shanrong Biotechnology's current stock value. Our valuation model uses many indicators to compare Shanrong Biotechnology value to that of its competitors to determine the firm's financial worth. Shanrong Biotechnology Corp is currently regarded as top stock in total asset category among its peers. It is rated below average in price to sales category among its peers . The ratio of Total Asset to Price To Sales for Shanrong Biotechnology Corp is about 47,749 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Shanrong Biotechnology's earnings, one of the primary drivers of an investment's value.Shanrong Price To Sales vs. Total Asset
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Shanrong Biotechnology |
| = | 24.78 K |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Shanrong Biotechnology |
| = | 0.52 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Shanrong Price To Sales Comparison
Shanrong Biotechnology is currently under evaluation in price to sales category among its peers.
Shanrong Biotechnology Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Shanrong Biotechnology, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Shanrong Biotechnology will eventually generate negative long term returns. The profitability progress is the general direction of Shanrong Biotechnology's change in net profit over the period of time. It can combine multiple indicators of Shanrong Biotechnology, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Shanrong Biotechnology Corp. operates as a project management and executive consulting company. Shanrong Biotechnology Corp. is based in Beverly Hills, California. Shanrong Biotechnology operates under Shell Companies classification in the United States and is traded on OTC Exchange.
Shanrong Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Shanrong Biotechnology. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Shanrong Biotechnology position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Shanrong Biotechnology's important profitability drivers and their relationship over time.
Use Shanrong Biotechnology in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Shanrong Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanrong Biotechnology will appreciate offsetting losses from the drop in the long position's value.Shanrong Biotechnology Pair Trading
Shanrong Biotechnology Corp Pair Trading Analysis
The ability to find closely correlated positions to Shanrong Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Shanrong Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Shanrong Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Shanrong Biotechnology Corp to buy it.
The correlation of Shanrong Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Shanrong Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Shanrong Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Shanrong Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Shanrong Biotechnology position
In addition to having Shanrong Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Money Funds Thematic Idea Now
Money Funds
Funds or Etfs that invest most if their asset in companies from financial sector such as commercial banks, insurance companies, investment funds, and real estate. The Money Funds theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Shanrong Pink Sheet Analysis
When running Shanrong Biotechnology's price analysis, check to measure Shanrong Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanrong Biotechnology is operating at the current time. Most of Shanrong Biotechnology's value examination focuses on studying past and present price action to predict the probability of Shanrong Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanrong Biotechnology's price. Additionally, you may evaluate how the addition of Shanrong Biotechnology to your portfolios can decrease your overall portfolio volatility.